Curative Biotechnology Inc (CUBT) — SEC Filings

Curative Biotechnology Inc (CUBT) — 2 SEC filings. Latest: S-1/A (Aug 1, 2025). Includes 1 S-1/A, 1 S-1.

View Curative Biotechnology Inc on SEC EDGAR

Overview

Curative Biotechnology Inc (CUBT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1 filed on May 6, 2024: Curative Biotechnology Inc (CUBT) filed a IPO Registration (S-1) with the SEC on May 6, 2024. Curative Biotechnology Inc. filed an S-1 registration statement with the SEC on May 6, 2024. The company was formerly known as Connectyx Technologies Corp, with a name change on May 22, 2007. The filing per

Sentiment Summary

Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Curative Biotechnology Inc is neutral.

Filing Type Overview

Curative Biotechnology Inc (CUBT) has filed 1 S-1/A, 1 S-1 with the SEC between May 2024 to Aug 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (2)

Curative Biotechnology Inc SEC Filing History
DateFormDescriptionRisk
Aug 1, 2025S-1/AS-1/A Filing
May 6, 2024S-1Curative Biotechnology Inc. Files S-1 Registration Statementlow

Risk Profile

Risk Assessment: Of CUBT's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Industry Context

Curative Biotechnology Inc. operates in the biotechnology sector, focusing on biological products.

Top Tags

S-1 Filing (1) · Curative Biotechnology (1) · SEC Registration (1) · Biotechnology (1) · Corporate Filing (1)

Key Numbers

Curative Biotechnology Inc Key Metrics
MetricValueContext
Filing Date20240506S-1 Registration Statement
Name Change Date20070522From Connectyx Technologies Corp
SEC File Number333-279159S-1 Filing

Frequently Asked Questions

What are the latest SEC filings for Curative Biotechnology Inc (CUBT)?

Curative Biotechnology Inc has 2 recent SEC filings from May 2024 to Aug 2025, including 1 S-1/A, 1 S-1. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of CUBT filings?

Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.

Where can I find Curative Biotechnology Inc SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Curative Biotechnology Inc (CUBT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Curative Biotechnology Inc?

Financial highlights for Curative Biotechnology Inc are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for CUBT?

The investment thesis for CUBT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Curative Biotechnology Inc?

Executive information for Curative Biotechnology Inc is extracted from SEC filings as they are enriched with AI analysis.

What are the main risk factors for Curative Biotechnology Inc stock?

Of CUBT's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.

What are recent predictions and forward guidance from Curative Biotechnology Inc?

Forward guidance and predictions for Curative Biotechnology Inc are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.